Using artificial intelligence to predict and prevent non-cancer mortality in patients with cancer: ARILIS study protocol

Aim: To present the ARILIS study aimed at assessing the use of artificial intelligence to analyze chest computed tomography (CT) data to predict and prevent non-cancer mortality in patients with cancer. Material and methods: This cohort study will include patients with cancer diagnosed in the Arkhangelsk region (AR) within the 2019–2023 period. The COVID-19 patients with pneumonia, patients with general medical conditions, and the population of the Know Your Heart Study are planned to be enrolled as control groups. To detect and quantify the CT signs of the cardiovascular, pulmonary, and bone disorders, the thoracic СT scans of all the subjects will be processed using the multi-targeted AI algorithm provided by the IRA Labs company. From the date of processing of the thoracic CT scans using the multi-targeted AI algorithm, the study subjects will be followed for new clinical diagnoses and all-cause mortality. Expected results: T he study will determine the prevalence of CT signs of the cardiovascular, pulmonary, and bone disorders in patients with cancer compared with the Know Your Heart Study population sample. It will also assess the incidence of cardiovascular, pulmonary, and bone events and all-cause mortality in patients with cancer compared with control groups, explore the potential of the IRA Labs’ multi-targeted AI algorithm in the assessment and reclassification of assessed risks in patients with cancer, and provide a software product for using mtIA in healthcare practice.

Authors

Institutions

Publication Details

Journal
Ekologiya Cheloveka (Human Ecology)
Published
2024-12-12
DOI
https://doi.org/10.17816/humeco635357
Citations
1
Primary Topic
Cardiac, Anesthesia and Surgical Outcomes
Type
article
Field-Weighted Citation Impact
0.40
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Using artificial intelligence to predict and prevent non-cancer mortality in patients with cancer: ARILIS study protocol

Sergey Nikolaevich Avdeev, Maxim Pisov, A M Grjibovski, М. Yu. Valkov et al.
1 citations
Ekologiya Cheloveka (Human Ecology)
Cardiac, Anesthesia and Surgical Outcomes
0.40
article

Using artificial intelligence to predict and prevent non-cancer mortality in patients with cancer: ARILIS study protocol

Sergey Nikolaevich Avdeev, Maxim Pisov, A M Grjibovski, М. Yu. Valkov, Mikhail Belyaev, Zelimkhan G. M. Berikkhanov, EA Petrash, Alexander V. Kudryavtsev, Eugenia Soboleva, D. V. Bogdanov, Alexey Shevtsov, Victor А. Gombolevskiy, Marina Sekacheva, Y. Ashikhmin, Andrey Dyachenko, Zhanna Belaya, V. V. Оmelyanovskiy, Valeria Chernina, Ekaterina Panina, Mariia Donskova, Farukh Yaushev, Regina Gareeva, Н.С. Серова, Maria V. Basova, Mariya N. Dugova, M BOGDANOV, Mikhail Yu. Goncharov, Vilgelm V. Volman, Aleksandr S. Gershtanskiy
article en
1 citations

Abstract

Aim: To present the ARILIS study aimed at assessing the use of artificial intelligence to analyze chest computed tomography (CT) data to predict and prevent non-cancer mortality in patients with cancer. Material and methods: This cohort study will include patients with cancer diagnosed in the Arkhangelsk region (AR) within the 2019–2023 period. The COVID-19 patients with pneumonia, patients with general medical conditions, and the population of the Know Your Heart Study are planned to be enrolled as control groups. To detect and quantify the CT signs of the cardiovascular, pulmonary, and bone disorders, the thoracic СT scans of all the subjects will be processed using the multi-targeted AI algorithm provided by the IRA Labs company. From the date of processing of the thoracic CT scans using the multi-targeted AI algorithm, the study subjects will be followed for new clinical diagnoses and all-cause mortality. Expected results: T he study will determine the prevalence of CT signs of the cardiovascular, pulmonary, and bone disorders in patients with cancer compared with the Know Your Heart Study population sample. It will also assess the incidence of cardiovascular, pulmonary, and bone events and all-cause mortality in patients with cancer compared with control groups, explore the potential of the IRA Labs’ multi-targeted AI algorithm in the assessment and reclassification of assessed risks in patients with cancer, and provide a software product for using mtIA in healthcare practice.

Ekologiya Cheloveka (Human Ecology)Vol. 31(4)
Northern (Arctic) Federal University (RU), North-Eastern Federal University (RU), Moscow Institute of Physics and Technology (RU), Sechenov University (RU), Endocrinology Research Center (RU), Artificial Intelligence Research Institute (ES), Arkhangel'skiy Klinicheskiy Onkologicheskiy Dispanser (RU), Federal State Budgetary Institution "Center for Expertise and Quality Control of Medical Care" (RU), Northern State Medical University (RU)
Openalex Percentile: Top 29%
Cardiac, Anesthesia and Surgical Outcomes
0.40
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.